GlassScriptPhysician profile
David Lillie
NPI 1952306201
$3,382.47
in general payments reported to CMS, 2019-2025
23 companies · $508 in 2025
The $508 reported for 2025 was more than what 79% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $589 · 2020: $215 · 2021: $653 · 2022: $383 · 2023: $408 · 2024: $626 · 2025: $508.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,529 · Education: $13.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,528.94 |
| Education | $13.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $980.60 | 2019-2025 | Xtandi, Myrbetriq |
| Janssen Biotech, INC. | $655.70 | 2019-2025 | Erleada, Carvykti, Rybrevant |
| Pfizer INC. | $536.51 | 2019-2025 | |
| Abbvie INC. | $140.02 | 2019-2023 | |
| Calyxo, INC. | $128.50 | 2024 | Cvac Aspiration System |
| Abbott Laboratories | $120.29 | 2021 | |
| Medtronic USA, INC. | $117.37 | 2019 | |
| Boston Scientific Corporation | $115.44 | 2021 | |
| Tempus Ai, INC | $88.56 | 2024-2025 | Xt Cdx |
| Novartis Pharmaceuticals Corporation | $69.65 | 2022-2023 | |
| Teleflex LLC | $60.86 | 2024 | Urolift |
| Olympus America INC. | $58.59 | 2024 | Itind System |
| Bayer Healthcare Pharmaceuticals INC. | $51.88 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $44.13 | 2023-2024 | Gemtesa |
| Accord Healthcare, INC. | $43.18 | 2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $37.97 | 2021-2022 | |
| Urovant Sciences INC | $31.40 | 2021-2022 | |
| Dentsply Ih Ab | $21.08 | 2025 | Lofric |
| Ferring Pharmaceuticals INC. | $18.36 | 2019 | |
| Dentsply Ih INC. | $17.66 | 2020 | |
| Urogen Pharma, INC. | $17.41 | 2023 | Jelmyto |
| Telix Pharmaceuticals | $15.71 | 2023 | Illuccix |
| Janssen Pharmaceuticals, INC | $11.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lillie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.